Mediterranean Journal of Hematology and Infectious Diseases (Jun 2023)

Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation

  • Howard Oster,
  • Ekaterina Sklyar,
  • Noa Golsdshmidt,
  • Moshe Mittelman

DOI
https://doi.org/10.4084/MJHID.2023.044
Journal volume & issue
Vol. 15, no. 1

Abstract

Read online

Background: Immune and inflammatory processes have known contributions to the pathogenesis of myelodysplastic syndromes (MDS). The use of inflammatory markers, minimally used in current practice, is examined.

Keywords